Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders
US5434156A · kind A · utility
19Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 1993 |
| Grant date | Jul 18, 1995 |
| Priority date | — |
| Expiry date | Oct 12, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the relief or prevention of withdrawal syndrome resulting from addiction to alcohol and/or the suppression of dependence on alcohol by administering to a person in need thereof, an effective amount certain diphenylbutyl-piperazine-carboxamides including 4-[4,4-bis(4-fluorophenyl)butyl]-N-ethyl-1-piperazine-carboxamide which is also known as amperozide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.